270 related articles for article (PubMed ID: 9054951)
1. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
[TBL] [Abstract][Full Text] [Related]
2. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
Wu MP; Tamada JA; Brem H; Langer R
J Biomed Mater Res; 1994 Mar; 28(3):387-95. PubMed ID: 8077254
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI
J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268
[TBL] [Abstract][Full Text] [Related]
4. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
[TBL] [Abstract][Full Text] [Related]
5. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
[TBL] [Abstract][Full Text] [Related]
7. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
[TBL] [Abstract][Full Text] [Related]
8. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.
Buahin KG; Brem H
J Neurooncol; 1995 Nov; 26(2):103-10. PubMed ID: 8787852
[TBL] [Abstract][Full Text] [Related]
9. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
Nagpal S
Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
[TBL] [Abstract][Full Text] [Related]
12. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
[TBL] [Abstract][Full Text] [Related]
13. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
[TBL] [Abstract][Full Text] [Related]
15. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
Lesniak MS; Upadhyay U; Goodwin R; Tyler B; Brem H
Anticancer Res; 2005; 25(6B):3825-31. PubMed ID: 16312042
[TBL] [Abstract][Full Text] [Related]
16. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
17. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
18. Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain.
Domb AJ; Rock M; Perkin C; Yipchuck G; Broxup B; Villemure JG
Biomaterials; 1995 Sep; 16(14):1069-72. PubMed ID: 8519927
[TBL] [Abstract][Full Text] [Related]
19. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.
Tamargo RJ; Myseros JS; Epstein JI; Yang MB; Chasin M; Brem H
Cancer Res; 1993 Jan; 53(2):329-33. PubMed ID: 8417826
[TBL] [Abstract][Full Text] [Related]
20. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
Emerich DF; Winn SR; Bartus RT
Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]